Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study TR Marques, S Natesan, EA Rabiner, GE Searle, R Gunn, OD Howes, ... Psychopharmacology 239 (11), 3439-3445, 2022 | 11 | 2022 |
Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia AF Pardiñas, SE Smart, IR Willcocks, PA Holmans, CA Dennison, ... JAMA psychiatry 79 (3), 260-269, 2022 | 57 | 2022 |
The Maudsley prescribing guidelines in psychiatry DM Taylor, TRE Barnes, AH Young John Wiley & Sons, 2021 | 1707 | 2021 |
Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: a multicenter positron emission tomography and magnetic resonance … A Egerton, A Murphy, J Donocik, A Anton, GJ Barker, T Collier, B Deakin, ... Schizophrenia bulletin 47 (2), 505-516, 2021 | 73 | 2021 |
Adenosine A TR Marques, S Natesan, EA Rabiner, GE Searle, R Gunn, OD Howes, ... | | 2021 |
Aberrant salience attribution and psychosis TT Winton-Brown, S Kapur, C Tamminga, J van Os, U Reininghaus, ... Psychotic Disorders: Comprehensive Conceptualization and Treatments, 442-450, 2020 | 1 | 2020 |
Antipsychotics circa 2020: What are we thinking? G Remington, S Kapur Neuropharmacology 175, 108181, 2020 | 2 | 2020 |
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study S Jauhar, M Veronese, MM Nour, M Rogdaki, P Hathway, FE Turkheimer, ... Molecular psychiatry 24 (10), 1502-1512, 2019 | 141 | 2019 |
Small sample sizes and a false economy for psychiatric clinical trials S Kapur, M Munafò JAMA psychiatry 76 (7), 676-677, 2019 | 11 | 2019 |
Regulation of dopaminergic function: An [F-18]-DOPA PET apomorphine challenge study in humans (vol 7, e1027, 2017) S Jauhar, M Veronese, M Rogdaki, M Bloomfield, S Natesan, ... TRANSLATIONAL PSYCHIATRY 9, 2019 | | 2019 |
Correction: Regulation of dopaminergic function: An [18F]-DOPA PET apomorphine challenge study in humans S Jauhar, M Veronese, M Rogdaki, M Bloomfield, S Natesan, ... Translational psychiatry 9 (1), 168, 2019 | | 2019 |
Bipolar disorder S Mayor BMJ: British Medical Journal 364, 2019 | 4 | 2019 |
The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: a positron emission tomography study S Jauhar, M Veronese, MM Nour, M Rogdaki, P Hathway, S Natesan, ... Biological psychiatry 85 (1), 79-87, 2019 | 68 | 2019 |
Determinants of antidepressant response: implications for practice and future clinical trials J Rabinowitz, N Werbeloff, FS Mandel, L Marangell, F Menard, S Kapur Journal of affective disorders 239, 79-84, 2018 | 7 | 2018 |
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 181 | 2018 |
Moment-to-moment associations between negative affect, aberrant salience, and paranoia SHW So, AKC Chau, ER Peters, J Swendsen, PA Garety, S Kapur Cognitive Neuropsychiatry 23 (5), 299-306, 2018 | 41 | 2018 |
Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis (vol 7, e1245, 2017) T Winton-Brown, A Schmidt, JP Roiser, OD Howes, A Egerton, ... TRANSLATIONAL PSYCHIATRY 8, 2018 | | 2018 |
Effects of risperidone and aripiprazole on serum levels of prolactin, testosterone and estradiol in female patients with schizophrenia XJ Jiang, FX Wu, JP Zhang, L Shi, JQ Hu, HZ Zhu, B Xiao, WC Lin, ... Drug Research 68 (07), 410-414, 2018 | 22 | 2018 |
ANUSCRIPT S Jauhar, M Veronese, MM Nour, M Rogdaki, P Hathway, S Natesan, ... | | 2018 |
Correction: Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans S Jauhar, M Veronese, M Rogdaki, M Bloomfield, S Natesan, ... Translational psychiatry 8, 2018 | | 2018 |